Overview of Dr. Xiao
Dr. Han Xiao is an oncologist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Overlook Medical Center. She received her medical degree from Sun Yat-Sen University of Medical Science and has been in practice 33 years. She is one of 498 doctors at Memorial Sloan Kettering Cancer Center and one of 47 doctors at Overlook Medical Center who specialize in Oncology. She has more than 50 publications and over 500 citings.
Office
136 Mountainview Blvd
Basking Ridge, NJ 07920Fax+1 908-542-3222
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 1991 - 1994
Sun Yat-Sen University of Medical ScienceClass of 1984
Certifications & Licensure
NY State Medical License 1994 - 2026
NJ State Medical License 2007 - 2025
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A histopathology-based artificial intelligence system assisting the screening of genetic alteration in intrahepatic cholangiocarcinoma.Han Xiao, Jianping Wang, Zongpeng Weng, Xiaoxuan Lin, Man Shu
British Journal of Cancer. 2025-02-01 - Intravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study.Liqi Shu, Favour Akpokiere, Daniel M Mandel, Thalia S Field, Christopher R Leon Guerrero
Neurology. 2024-10-08 - 2 citationsEfficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Sta...Qi Zhang, Shaonan Fan, Xiaohong Xu, Shisuo Du, Guangying Zhu
International Journal of Radiation Oncology, Biology, Physics. 2024-10-01
Journal Articles
- Long‐Term Quality of Life in Older Patients with HPV‐Related Oropharyngeal CancerHan Xiao, Nancy Y Lee, Head & Neck
- Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast CancerHan Xiao, Travis S Young, Angewandte Chemie
Press Mentions
Targeted, Anti-Clotting Meds Had Less Risk of Major Bleeding for Rare, Deadly StrokesFebruary 10th, 2022- Drug Doubles down on Bone Cancer, MetastasisJune 23rd, 2021
- First Person Profile: George J. Bosl, MDJanuary 12th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
